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Abstract
Phycocyanobilin (PCB) binds with high affinity (2.2 x 106 M-1 at 25˚C) to human serum albu-
min (HSA) at sites located in IB and IIA subdomains. The aim of this study was to examine
effects of PCB binding on protein conformation and stability. Using 300 ns molecular dynam-
ics (MD) simulations, UV-VIS spectrophotometry, CD, FT-IR, spectrofluorimetry, thermal
denaturation and susceptibility to trypsin digestion, we studied the effects of PCB binding on
the stability and rigidity of HSA, as well as the conformational changes in PCB itself upon
binding to the protein. MD simulation results demonstrated that HSA with PCB bound at any
of the two sites showed greater rigidity and lower overall and individual domain flexibility
compared to free HSA. Experimental data demonstrated an increase in the α-helical content
of the protein and thermal and proteolytic stability upon ligand binding. PCB bound to HSA
undergoes a conformational change to a more elongated conformation in the binding pock-
ets of HSA. PCB binding to HSA stabilizes the structure of this flexible transport protein,
making it more thermostable and resistant to proteolysis. The results from this work explain
at molecular level, conformational changes and stabilization of HSA structure upon ligand
binding. The resultant increased thermal and proteolytic stability of HSA may provide
greater longevity to HSA in plasma.
Introduction
Spirulina (genus Arthrospira), filamentous blue-green microalga, has been used as food for
centuries, as it is one of the richest known sources of proteins, vitamins, macro- and micro-
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nutrients and essential fatty acids [1]. Numerous in vitro and in vivo studies have shown the
various health benefits of Spirulina, mainly attributed to calcium spirulan and C-phycocyanin
(C-PC) [2]. Phycocyanobilin (PCB), the non-protein component of C-PC, is open-chain tetra-
pyrrole chromophore (Fig 1A), responsible for the intense blue color of the protein. PCB,
whose structure is similar to that of biliverdin, is metabolized to phycocyanorubin by biliver-
din reductase, in a manner similar to that of biliverdin conversion [3]. PCB has been shown to
be a potent inhibitor of NADPH oxidase, the major source of intracellular oxidative stress [4].
PCB has strong antioxidant and anti-inflammatory effects, being able to mimic biliverdin
function. Since the availability of biliverdin supplies could be inadequate for large population
groups, both C-PC and PCB have been proposed as its therapeutic replacements to prevent
cancer and many other diseases [4].
One of the most extensively investigated proteins, human serum albumin (HSA) is an
important carrier of many physiological ligands and bioactive compounds, such as fatty acids,
steroids, vitamins, metabolites and different drugs. HSA is a 66 kDa protein with three main
domains (Fig 1B): domain I (residues 1–195), domain II (196–383) and domain III (384–585).
Each domain of HSA is divided into two subdomains A and B containing 6 and 4 helices,
respectively [5,6].
Among the seven distinct fatty acid binding sites of HSA [7], two main binding sites have
been reported and first characterized by Sudlow et al. [8]. Sudlow’s binding site 1, known as
the warfarin-azapropazone site, located in the IIA subdomain, is capable of accommodating
bulky heterocyclic anion ligands. The aromatic compounds, including ibuprofen, flurbiprofen
and diazepam, are found to bind in the hydrophobic pocket of Sudlow’s binding site 2, located
Fig 1. A) PCB chemical structure with labeled (A-D) pyrolle rings (oxygen atoms are in red and nitrogen in blue); B) Schematic of HSA structure
with domains and ligand binding sites labeled; Radius of gyration (Rg) values (C) and 2D RMDS plots for free HSA (D), HSA-PCB(IIA) (E), and
HSA-PCB(IB) (F) during 300 ns molecular dynamic simulation.
doi:10.1371/journal.pone.0167973.g001
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in the subdomain IIIA, known as the indole-benzodiazepine site [8]. Recent spectroscopic
studies have shown the versatility of HSA molecule to accommodate both anionic and neutral
molecules in Sudlow’s binding site 1 [9]. Additionally, HSA has another important ligand-
binding site known as heme-binding site in subdomain IB [10].
Despite numerous studies, there is controversy about the location of the primary high-affin-
ity bilirubin-binding site on albumin. A crystallographic study placed the binding site for bili-
rubin photoisomer, 4Z,15E-bilirubin, within the subdomain IB [11], while numerous studies
pointed to the hydrophobic pocket of the subdomain IIA as the primary high-affinity binding
site for bilirubin [12]. We showed that binding sites for PCB are located in IB (heme site) and
IIA (Sudlow’s site I) subdomains, similar to that of its structural homolog bilirubin, and that
due to its high affinity PCB competes with bilirubin for binding to HSA [13].
High flexibility consequent to ligand binding and an extraordinary capacity to accommodate
a structurally diverse set of ligands at different binding sites, make HSA a non-uniform ligand-
binder, capable of changing binding site conformations. Abundance of this molecule in plasma
makes it a prominent factor in the pharmacokinetic behavior of a large variety of drugs, as it can
cause changes in their efficiency and delivery rate [14]. Therefore, it is essential to understand
how this major plasma carrier protein, capable of binding ligands at different binding sites,
changes its conformation and stability upon binding a particular ligand at its specific binding
site. Binding of food-derived ligands such as vitamin B12 [15], fatty acids [16], lupeol [17], and
phloretin [18] have also been reported to stabilize the conformation of HSA. However, there is
no comprehensive study using computational and experimental methods, which demonstrates
the stabilization of HSA structure by the binding of biologically active food component.
In order to elucidate the structural changes of HSA and PCB when ligand is bound in two
different (IB and IIA) HSA binding sites, the three systems: free HSA, PCB bound to heme site
(HSA-PCB(IB)) and PCB bound to Sudlow’s site 1 (HSA-PCB(IIA)) were examined by 300 ns
molecular dynamics (MD) simulation. Using UV-VIS spectroscopy, circular dichroism (CD),
Fourier Transform Infrared (FT-IR) spectroscopy, fluorescence spectroscopy and trypsin
digestion assay, we examined the effects of PCB binding on HSA stability and conformation.
Furthermore, following MD simulations of HSA-PCB complexes, we probed binding of vari-
ous HSA ligands to their binding sites by molecular docking.
Materials and Methods
Materials
Essentially fatty acid free HSA (type A1887), and porcine trypsin (1800 U/mg) were purchased
from Sigma-Aldrich (USA) and used without further purification. HSA concentration was
determined using an extinction coefficient of 35 700 M-1 cm-1 at 280 nm. Protease inhibitors
N-p-Tosyl-L-phenylalanine chloromethyl ketone (TPCK;97.0%) and phenylmethanesulfo-
nyl fluoride (PMSF;99.0%) were from Sigma-Aldrich. PCB was purified from commercial
Hawaiian Spirulina pacifica powder (Nutrex, USA) and quantified by measuring absorbance at
680 nm as previously described [13]. All measurements were done in 20 mM Tris buffer, pH
7.4 (except for trypsin digestion study, see below). Final concentrations of methanol in
HSA-PCB mixtures did not exceed 1% (v/v). All other chemicals were of analytical reagent
grade and Milli-Q water (Millipore, Molsheim, France) was used throughout the experiments.
Absorbance spectroscopy measurements
UV-VIS absorption spectra were recorded using a NanoDrop 2000c spectrophotometer
(Thermo Scientific, USA). The measurements of 18 μM PCB in the presence and absence of
equimolar HSA were made in the range of 310–700 nm at 25˚C.
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Circular dichroism measurements
CD experiments were performed on a Jasco J-815 spectropolarimeter (JASCO, Japan), under
temperature controlled conditions (Peltier control system). Far-UV CD spectra of 18 μM HSA
in the presence and absence of equimolar PCB were recorded in the range 180–260 nm, using
a cell with a 0.1 mm path length and with an accumulation of three scans. Other relevant
details are in S1 Text.
Monitoring of HSA thermal denaturation was performed in the temperature range 37–
87˚C, increasing the temperature at the rate of 4˚C/min between 37 and 61˚C and 2˚C/min
between 61–87˚C. After 1 min of equilibration at each temperature, ellipticity was measured at
222 nm or far-UV CD spectra in the range 205–255 nm were recorded, using a cell with a 10
mm path length. For each spectrum, two scans at a scanning speed of 100 nm/min were aver-
aged. Concentrations of HSA and PCB were 0.5 μM, with path length cells of 1 cm. Results
were expressed as temperature dependence of percentage of initial ellipticity (at 37˚C).
Obtained plots were fitted with a sigmoidal function. The inflection point in the plot was taken
as melting point of HSA [19].
Fluorescence spectroscopy measurements
Fluorescence measurements were done on FluoroMax1-4 spectrofluorometer (HORIBA Sci-
entific, Japan) under temperature controlled conditions (Peltier control system), with the
width of the excitation and emission slit both adjusted to 5 nm and with cells of 1-cm path
length. Temperature dependence of HSA fluorescence was studied in the range of 38–78˚C,
increasing the temperature at the rate of 2˚C/min, with equilibration time for each tempera-
ture set to 1 min. Concentrations of HSA and PCB were 0.5 μM. Single wavelength emission at
340 nm or emission spectra in the range of 290–400 nm were recorded after excitation at 280
nm.
FT-IR spectroscopy measurements
FT-IR data were obtained using a Nicolet 6700 FT-IR spectrometer (Thermo Scientific, USA)
equipped with a Germanium attenuated total reflection (ATR) accessory, a thermoelectrically
cooled deuterated triglycine sulfate (DTGS TEC) detector and a XT-KBr beam splitter. The
protein secondary structure composition was determined from the shape of the amide I band,
located around 1650–1660 cm−1. Fourier self-deconvolution and secondary derivative were
applied to the range of 1700–1600 cm−1 to estimate the number, position, and areas of the
component bands. Other relevant details are included in the S1 Text.
Trypsin digestion of HSA
Trypsin digestion of HSA in the presence and absence of PCB was performed in 50 mM Tris
buffer (pH 8.0) at 37˚C. PCB (stock solution in methanol) was added to HSA solution at an
equimolar concentration (3.8 μM). An equivalent volume of methanol was added in the con-
trol sample (HSA without PCB). Both samples were pre-incubated with 10 μM TPCK (final
concentration) to prevent chymotrypsin activity. Digestion started with the addition of trypsin
solution in 1 mM HCl (1 mg/mL), wherein the mass ratio of HSA/trypsin was 25. Aliquots of
60 μL were taken at 0.5, 2, 5, 10, 30, and 60 min after initiation of the incubation. Each aliquot
was quenched with 1 mM PMSF (final concentration). SDS polyacrylamide gel electrophoresis
(SDS-PAGE) of digests was performed under reducing conditions [20] and the gels were
stained with Coomassie Brilliant Blue R-250. Gel images were scanned and the band intensities
were quantified by densitometry using ImageJ software, considering the band intensity of
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HSA without trypsin (at 66 kDa) as 100%. The decay rate of HSA was fit to an exponential
model with Origin software (USA), using the equation: I = a + b e−kt, where I and t represent
relative band intensity and time, respectively, while k is rate constant of digestion. The rate
constant, as well as parameters a and b, were determined by the fitting process, and after that, I
was substituted with 0.5 in order to calculate the protein half-life.
Computational details
The initial HSA receptor model was the crystal structure with PDB ID: 1BM0. The protonation
state of each titratable amino acid was estimated using the H++ program by finite difference
Poisson-Boltzmann (FDPB) continuum electrostatics method [21]. The AutoDock Vina pro-
gram (version 1.1.2) was used for all dockings [22]. The exhaustiveness parameter was set to
100. The ligand was assigned CGenFF force field charges and non-bonded parameters, while
other atom parameters were obtained from Hessian, calculated after geometric optimization
on the 6-31G level of theory by Gaussian 09 [23]. All parameters were generated using the
VMD 1.9.1 program. All MD simulations were performed by applying the NAMD 2.9 pro-
gram [24]. Starting structures were solvated in a periodic box of TIP3P water, followed by neu-
tralization (by adding 150 mM NaCl) to simulate physiological conditions. A CHARMM27
force field [25] was used for protein and water. The obtained system was set to cascade 10,000
steps minimization on 310 K, followed by 250 ps equilibration in NVE ensemble with 1 fs step
size. Next, the system was set to 300 ns production run in NPT dynamics using the Langevin
piston pressure control at 310 K and 1.01325 bars. The Langevin damping coefficient and pis-
ton decay was set as 1 ps−1 and 10 fs, respectively. Periodic boundary conditions and the Parti-
cle-mesh Ewald method were implemented for a complete electrostatic calculation. The cutoff
for non-bonded interactions was set to 9 Å, with switching function at 8 Å. The non-bonded
list generation was stopped at 11 Å. The production phase was carried out with time step of 2
fs. The trajectory was stored every 1 ps and further analyzed with the VMD (version 1.9.2) [26]
using Tcl scripts for root-mean-square deviations (RMSD), root-mean-square fluctuations
(RMSF), and radius of gyration (Rg). A window-size of 20 frames with moving trajectory was
used for RMSF calculations.
Molecular graphics were created using Discovery Studio Viewer 3.5 (Accelrys Software Inc.
(2007) Discovery Studio Viewer, Release 3.5. Accelrys Software Inc., San Diego; http://
accelrys.com/products/discovery-studio/).
Results
MD simulation of HSA and HSA-PCB complex
Molecular dynamics simulation is the most comprehensive computational method for predict-
ing the time assessment of a molecular system of interacting particles; it can also supply knowl-
edge on the fluctuations and conformational alterations of macromolecules. Extensive MD
study was conducted to examine the stability of HSA and its complexes with PCB by evaluating
RMSD, RMSF, and Rg. All values of the atoms in the unliganded and liganded protein in
respect to the initial structures were calculated after global peptide backbone alignment up to
300-ns trajectories for all systems. In addition, 2D RMSD plots representing RMSD values
between each frame of the simulation (therefore 2D) were analyzed for observing the confor-
mational changes of HSA and its complexes with PCB during simulation. In our previous
study [13], we computationally predicted two binding sites for PCB on HSA, identical to those
of bilirubin (subdomains IB and IIA). The MD simulation study enabled us to refine these
PCB-binding sites and to better define interactions at both binding sites (S1 Fig, S1 Table and
S2 Text).
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RMSD values of the Cα-atoms of HSA and HSA-PCB complexes indicated that all systems
reached equilibrium, oscillated around an average value, and remained stable until the end of
the simulation (Figure A in S2 Fig). According to the 2D RMSD plot (where the squares along
the diagonal of the plot indicate intervals of snapshots having structural similarities), free HSA
passed through three different conformations (Fig 1D). From the start of 300 ns MD simula-
tion, HSA resided in a single conformation for about 50 ns, and then transitioned into a con-
formation distinct from the first one. It held this (or similar) structure until 230 ns, and then
transitioned into its final conformation. The light blue crosses (localized peaks in RMSD
value) indicate that the final conformation has structural similarities to the intermediate state,
but not to the starting conformation. HSA adopted only two clearly distinct conformations
when PCB was bound at the IIA site (Fig 1E). It transited from one conformation to another at
170 ns, and there were low structural similarities between these conformations. In contrast,
HSA having PCB bound at site IB retained its starting conformation until the end of simula-
tion (Fig 1F). Thus, 2D RMSD analysis indicates HSA rigidification upon PCB binding, with a
more prominent effect for binding of PCB at site IB.
The Rg value is a measure of the compactness of the system during simulation. In contrast
to free HSA, which showed a fluctuation in Rg during the entire simulation (Fig 1C), HSA
with PCB bound to site IIA clearly reached equilibrium at about 170 ns, at which it adopted its
final conformation, as indicated by the 2D RMSD analysis (Fig 1F). The lower plot of
HSA-PCB(IB) during the entire simulation period implies that this form may have a noticeably
more compact conformation, in comparison to free HSA and HSA-PCB(IIA). Therefore, in
parallel with RMSD, Rg analysis suggests that liganded HSA is more stable than its free form,
and that PCB binding at site IB stabilizes HSA from the start, while binding at site IIA acceler-
ates it to reach equilibrium.
The local protein mobility was analyzed by calculating the time-averaged RMSF values of
pure HSA and both HSA-PCB complexes. Generally, the atomic fluctuations were found to be
very similar to those of pure HSA and the HSA-PCB complexes (Fig 2A). However, local
changes upon binding of the ligand occurred not only in the binding sites but also in the dis-
tant regions of the protein, which may suggest an overall conformational change of the protein.
Binding of PCB to the IB-binding site caused a decrease in RMSF of subdomain IB (Fig 2C).
Residues (115–186 aa region) involved in PCB binding at site IB (S2 Text and S1 Table) syner-
gistically rigidified the whole IB region. Although binding of PCB to site IIA did not notably
rigidify the IIA subdomain, there was an increase in flexibility in the region (270–285 aa) that
is not involved in binding (Fig 2D). The most pronounced rigidification was observed in sub-
domain IIIB in both examined systems with bound PCB, with a greater effect when PCB was
bound to subdomain IB (Figure D in S3 Fig). Binding of PCB to the site located in subdomain
IB caused a pronounced increase in the RMSF of residues in subdomain IIB (350–375 aa)
(Figure B in S3 Fig), while binding of PCB to the site IIA caused a slight increase in flexibility
in subdomain IB (100–120 aa) (Fig 2C).
As PCB binding increased the rigidity of some HSA regions and increased the flexibility of
the others, to get a quantitative insight into the flexibility of individual domains in all three sys-
tems, we calculated the sum of RMSF values of all amino acid residues for every domain (Fig
2B). During the MD simulation of free HSA, subdomain IIIB showed the highest flexibility,
twice as high as that of subdomains IIA and IIB. PCB binding at site IB induced an increase of
13% and 14% in the rigidity of subdomains IB and IIIB, respectively, and an increase of 10% in
the flexibility of subdomain IIB. PCB binding at site IIA induced a prominent increase of 7%
in the rigidity of subdomain IIIB. It is interesting to note that increased rigidity of subdomains
IIIB and IB, when PCB bound at IB site, was also the consequence of an interaction between a
loop in subdomain IB and an α-helix in subdomain IIIB (Figure A in S4 Fig). Positioning of
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PCB at site IB allowed the formation of alternating hydrogen bonding of Arg114 (IB) with
Glu520 and Ala511 (IIIB), resulting in the stabilization of both subdomains IB and IIIB
(Figure B in S4 Fig). In free HSA, there was almost no interaction between the two subdomains
(Figure D in S4 Fig); when PCB was bound at site IIA, there was a transitory (about 100 ns)
interaction (Figure C in S4 Fig), resulting in lower stabilization, as compared to that seen in
HSA-PCB(IB).
Taking into account RMSF values for all HSA residues, PCB binding to site IB and IIA
caused an increase of 5.4% and 2.1%, respectively, in the overall rigidity of HSA, suggesting
that PCB binding at any two sites stabilizes the protein structure. These changes in RMSF are
also reflected in the movement of subdomains in HSA, as shown in Fig 3A, 3B and 3C.
Overall, the MD simulation data suggest a conformational change in HSA upon binding of
PCB, which can influence the binding sites for other ligands (especially heme-binding site may
be influenced upon PCB binding to Sudlow’s site I). According to the MD simulation data, the
binding of PCB also causes greater compactness of the protein and reduces its conformational
mobility, suggesting that HSA, when complexed with PCB, is more stable than the free
protein.
Fig 2. Calculated RMSF values (Å) from molecular dynamics simulation of free HSA, HSA-PCB(IB), and HSA-PCB(IIA). RMSF
values along whole protein sequence (A), sum of RMSF values of each HSA domain (B), and difference of RMSF values between
PCB-HSA complexes and free HSA, with marked amino acid (aa) residues involved in PCB binding for site IB (C), and for site IIA (D).
doi:10.1371/journal.pone.0167973.g002
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Phycocyanobilin bound to HSA undergoes a conformational change to a
more stretched conformation
To get insight into conformation of ligand during the MD simulation, RMSD, RMSF and dihe-
dral angles between pyrolle rings of PCB were calculated. The RMSD of the ligand reached
equilibrium after 110 ns and 170 ns when bound to IB and IIA sites, respectively (Figure B in
S2 Fig). In comparison with values of the protein backbone, ranging from 2.5–4.5 Å (Figure A
in S2 Fig), RMSD of bound ligand ranged from 1.7–3.5 Å, indicating that protein structure
shows higher fluctuations then ligand, in accordance to the high affinity of the ligand, and sug-
gests that the docked complex structure in both cases is stable throughout the MD simulation.
When PCB is bound at site IIA, dihedral angle between rings A and B is stable during simula-
tion (Figure A in S5 Fig), as well as angle between rings B and C (Figure B in S5 Fig). However,
dihedral angle between rings C and D (Figure C in S5 Fig) dramatically change at 169 ns, at
the same time at which HSA change its conformation (Fig 1C and 1E), suggesting simulta-
neous conformational change of protein and ligand. On the contrary, when PCB is bound at
site IB all dihedral angles become stabilized after 107 ns (S5 Fig). In both cases angles between
rings B and C are the most stable (Figure B in S5 Fig). RMSFs of all heavy atoms of PCB
(Figure A in S6 Fig) are similar when PCB is bound to IB or IIA site (Figure B in S6 Fig), with
atoms of the pyrrole rings showing the lowest flexibility. Atoms of internal rings (B and C) are
more rigid then external ones, with central bridge atoms showing far the lowest fluctuation, in
accordance to observed the highest stability of dihedral angles between rings B and C. These
Fig 3. Conformational changes of free HSA (A), HSA-PCB(IB) (B), and HSA-PCB(IIA) (C) during molecular dynamics simulation.
The starting structures (0 ns) are represented in grey and the structures from the last snapshot (300 ns) in black (free HSA), blue
(HSA-PCB(IB)) and red (HSA-PCB(IIA)). The red arrows direct to regions of PCB-bound HSA with increased flexibility, and blue one to
decreased flexibility compared to flexibility of free HSA (black arrows); Conformational changes of PCB bound to site IB (D) and site
IIA (E) during molecular dynamics simulation. The starting structures (0 ns) are represented in grey and the structures from the last
snapshot (300 ns) in blue (PCB-IB) and red (PCB-IIA); (F) Absolute values of dihedral angles of starting PCB structure and of
average dihedral angles calculated before and after PCB conformational change (at 107 ns for PCB-IB and at 169 ns for
PCB-IIA).
doi:10.1371/journal.pone.0167973.g003
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results suggest that PCB is stable protein-bound during simulation time and that it undergoes
a conformational change in the binding site.
In order to determine conformations of PCB bound to HSA, dihedral angles between pyr-
role rings of PCB were calculated using data obtained by MD study. Average absolute values of
dihedral angles during 300 ns MD simulation, before and after PCB conformational change (at
107 ns for HSA-PCB(IB) and at 169 ns for HSA-PCB(IIA)) are shown in Fig 3F. Dihedral
angles of 0˚-90˚ can been ascribed to syn (S) conformers, while angle of 90˚-180˚ represents
anti (A) conformers. Taking into account that free PCB has SSS, cyclic, helical conformation
[27] values at Fig 3F indicate that PCB bound to HSA has more stretched conformation in
comparison to its free form. Conformer at subdomain IIA resides in SSA conformation until
its conformational change at 169 ns, while conformer at subdomain IB adopts elongated SSA
conformation after its conformational change at 107 ns, therefore being more elongated at the
end of simulation. Overlaid structures of bound PCB before and after MD simulation are
shown at Fig 3D and 3E.
The UV-VIS spectrum of pure PCB shows two characteristic absorption maxima at 362 and
610 nm (Fig 4A). Addition of HSA results in shift of absorption maximum from 362 nm to
longer wavelengths (up to 368 nm) with decreasing absorbance and an increase in the intensity
of absorbance in VIS region, followed with blue shift to 605 nm. These observations confirm
that PCB conformation changes after addition of HSA.
HSA conformation changes by interaction with PCB
The CD spectra of HSA displays two negative bands in the UV region at 208 nm and 222 nm,
characteristic of the α-helical structure of protein. As shown in Fig 4B, PCB alone does not
show optical activity in this region. The addition of PCB to HSA leads to an increase in nega-
tive ellipticity of minima without any significant shift of the peaks or overall protein spectrum
shape change. The α-helix content of HSA increased from 49.3±1.7% to 54.5±2.4% upon PCB
binding at a molar ratio PCB/HSA of 1:1, implying that PCB binding results in conformational
change that stabilizes HSA structure by increasing its α-helix content.
Additional evidence regarding the effect of PCB binding on HSA structure came from
FT-IR study (Fig 4C, S3 Text and S7 Fig). Free HSA contains α-helices (50.4±2.1%), β-sheets
(29.8±1.3%), and β-turns (11.0±0.5%). These results are consistent with the literature data
[28]. Addition of PCB to HSA, increased the α-helix content to 55.2±1.8%, confirming the
results obtained by CD. The total β-sheet and β-turn content was virtually unchanged; how-
ever, the random coil content was reduced from 8.8±1.3% to 4.8±0.7% (S2 Table), suggesting
that upon PCB binding HSA stabilization is reflected by increase in α-helix content on the
expense of random coil.
Increase in thermal stability of HSA by PCB binding
In order to investigate the effect of PCB binding on HSA thermal stability, we monitored its
thermal denaturation by decrease of ellipticity at 222 nm because of α-helical content loss (Fig
5A). The melting curve for HSA-PCB system was similar to that of free HSA; however, it was
observed that PCB has limited inhibitory effect on HSA thermal denaturation. Tm values
obtained by sigmoidal fit of melting curves indicate that compared to free HSA (Tm = 70˚C)
HSA-PCB complex has greater thermal stability (Tm = 71.4˚C). In addition, far-UV CD spec-
tra recorded at each temperature also show increased HSA thermal stability by PCB binding
(Figures A and B in S8 Fig). Thermal denaturation was also reflected by decrease in intrinsic
fluorescence of Trp214 located in IIA subdomain [6] (Fig 5B). However, unlike CD, intensive
decrease of fluorescence starts at lower temperatures (40˚C). Therefore, it appears that
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Fig 4. (A) UV-VIS spectra of free HSA, free PCB, and HSA-PCB complex (molar ratio 1:1); (B) Far-UV
circular dichroism spectra of HSA in the absence (a) and presence (b) of PCB. Dot line curve shows
spectrum of PCB; (C) The FT-IR spectra of free HSA (solid line), and the FT-IR difference spectra of
HSA-PCB complex (molar ratio 1:1) (dot line). All spectra were recorded in 20 mM Tris buffer (pH 7.4) with
samples of 18 μM HSA and 18 μM PCB.
doi:10.1371/journal.pone.0167973.g004
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fluorescence loss at lower temperatures may not be a consequence of protein conformational
changes because thermal quenching also occurs here [29]. However, there are differences in
melting curves of free HSA and HSA-PCB complex, especially at temperatures above 60˚C.
The presence of PCB inhibits decrease in HSA fluorescence at higher temperatures, indicating
that PCB stabilizes HSA structure. Furthermore, the change in the fluorescence emission spec-
tra (λ ex = 340 nm) recorded at each temperature shows increase in thermal stability of HSA
by PCB binding (Figures C and D in S8 Fig).
Resistance of HSA-PCB complex to trypsin digestion
Flexibility of protein domains influences protein digestion because flexible loops of proteins
can better accommodate catalytic sites of proteases. As the HSA-PCB complex is more rigid
than the free HSA, it might be expected that the ligand binding will influence the proteolytic
degradation of the protein.
HSA digestibility in the presence and absence of PCB was analyzed by SDS-PAGE after
trypsin digestion. The results demonstrate that trypsin in 10 min digested majority of free
HSA (Mw 66 kDa), producing relatively large fragments. On the other hand, HSA-PCB com-
plex is digested slower than HSA, and the large digestion resistant peptides of HSA (Mw of 35
and 14 kDa) appear later during the digestion reaction (Fig 5C). By fitting the intensity of the
Fig 5. (A) Temperature dependence of 0.5 μM HSA ellipticity at 222 nm in the presence and absence of 0.5 μM PCB; (B)
Temperature dependence of 1 μM HSA fluorescence at 340 nm in the presence and absence of 1 μM PCB (λEX = 280 nm); (C)
SDS-PAGE profile after trypsin digestion of 3.8 μM HSA in the presence and absence of 3.8 μM PCB. Lane K: HSA without trypsin;
lane M: MW markers; lanes 1–6 correspond to digestion times 0.5, 2, 5, 10, 30, and 60 min without PCB, respectively; lanes 7–12
correspond to digestion times 0.5, 2, 5, 10, 30 and 60 min with PCB, respectively.
doi:10.1371/journal.pone.0167973.g005
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intact HSA band obtained by densitometry into an exponential decay curve (S9 Fig), we esti-
mated half-life of free HSA to be 4.9 min, while PCB prolonged half-life of HSA to 13.9 min.
Complexation of PCB with HSA affects the binding of other physiological
ligands
MD simulation study of conformational changes occurring upon binding of PCB to any of its
two possible binding sites on HSA allowed us to theoretically investigate effects of multiple
ligands binding to HSA or HSA in a complex with PCB. We inspected several physiologically
relevant ligands: bilirubin, warfarin, indomethacin, fusidic acid, thyroxine, diazepam, ibupro-
fen, diclofenac, hemin, azapropazone, myristic acid, and PCB. The approach involved docking
of the ligands to the initial protein conformation and observation of the conformation that
protein adopts after MD simulation (as shown above, Fig 3A, 3B and 3C).
During MD simulation HSA changed its conformation, and therefore, binding scores of
almost all ligands after simulation were lower than they were in the initial crystal structure
(Table 1). After MD simulation of HSA with PCB bound at site IIA, binding scores of ligands
to sites IA, IB, IIIA, and IIIB were mostly reduced; however, after MD simulation of HSA with
PCB bound at site IB, binding scores were either reduced or increased. It is interesting that
Table 1. Binding scores (kcal mol-1) of different ligands docked to free and phycocyanobilin (PCB)-bound human serum albumin (HSA; at site IB
or IIA), before and after 300 ns of molecular dynamics (MD) simulation.
Ligand Binding
site
Free HAS
before MD
Free HAS
After MD
HSA-PCB(IB)
after MD
HSA-PCB(IIA)
after MD
Diff free HSA after MD—
HSA-PCB(IB) after MD
Diff free HSA after MD—
HSA-PCB(IIA) after MD
Warfarin IIA -8.8 -7.5 -7.0 ------ -0.5 ------
Indomethacin IB -8.4 -7.4 ------ -6.7 ------ -0.7
IIA -8.2 -6.9 -6.9 ------ 0.0 ------
Bilirubin IB -9.8 -7.5 ------ -8.3 ------ 0.8
IIA -8.3 -7.6 -6.1 ------ -1.5 ------
Fusidic acid IB -8.8 -7.4 ------- -6.8 ------ -0.6
IIIB -6.5 -5.3 -4.7 -5.3 -0.6 0.0
Thyroxine IIA -6.4 -6.0 -5.7 ------ -0.3 ------
IIIA n/a -6.4 -5.3 -4.4 -1.1 -2.0
IIIB -5.3 -5.4 -3.6 -5.0 -1.8 -0.4
Hemin IB -8.2 -7.8 ------ -6.6 ------ -1.2
Diazepam IIIA n/a -6.9 -7.2 -6.3 0.3 -0.6
Ibuprofen IIB -6.8 -6.2 -6.8 -6.8 0.6 0.6
IIIA -5.9 -6.1 -6.5 -6.4 0.4 0.3
Azapropazone IB -8.1 -7.3 ------ -6.8 ------ -0.5
IIA -8.1 -7.2 -6.3 ------ -0.9 ------
Diclofenac IB -7.3 -7.0 ------ -6.1 ------ -0.9
IIA -8.1 -6.2 -6.4 ------ 0.2 ------
IIB -7.2 -6.6 -7.1 -6.9 0.5 0.3
Myristic acid IIA -5.9 -5.3 -5.3 ------ 0.0 ------
IB -6.0 -5.6 ------ -4.4 ------ -1.2
IA -4.4 -4.2 -4.3 -4.6 0.1 0.4
IIB -5.6 -4.9 -5.2 -5.8 0.3 0.9
IIIA -6.0 -5.4 -5.6 -5.1 0.2 -0.3
IIIB -3.8 -4.4 -4.8 -4.5 0.4 0.1
PCB IB -10.2 -8.9 ------ -8.7 ------ -0.2
IIA -10.0 -8.5 -8.1 ------ -0.4 ------
doi:10.1371/journal.pone.0167973.t001
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binding scores of ligands bound to site IIB increased because of the presence of PCB at site IB
or IIA. It can be concluded that conformational change induced by PCB binding to site IIA in
general negatively influences the binding of different ligands to the sites IA, IB, IIIA, and IIIB.
On the other hand, the conformation that HSA adopts when PCB binds to any of its two high-
affinity sites is more favorable for binding of ligands that specifically bind to site IIB. Our data
imply that HSA structure stabilization by PCB binding and the accompanying conformational
change might influence the binding of other ligands (including PCB) to other binding sites.
Discussion
We have shown that an algae-derived tetrapyrrole pigment, when bound to the major plasma
carrier protein, stabilizes its structure and provides protection from proteolytic degradation.
Our results also indicate that for proteins binding multiple ligands, conformational changes
upon binding of tetrapyrrole ligands may have various effects on binding of other physiologi-
cally relevant ligands/drugs of HSA.
In aqueous solutions, PCB adopts a monoanionic helicoidal conformation with the first car-
boxylic group ionized [13]. Rotation about exocyclic single bonds of the methine bridges, and
protonation state of propionic acid residues in PCB, produces various conformers with spec-
troscopically different characteristics [30], a property we exploited for analyzing conformation
of the ligand bound to HSA. PCB possesses high conformational flexibility, but the cyclic heli-
cal SSS conformation is the most stable [27]. Binding of PCB to HSA induced changes in the
absorption spectrum of PCB, with a blue shift and increase in intensity of the VIS peak and a
red shift and decrease in intensity of the UV peak. This indicates that PCB bound to HSA has a
different, slightly more stretched conformation in comparison to its free form, in agreement
with calculated transitions for protonated, more extended PCB conformers [31]. Red shift and
decrease in intensity of the bilirubin peak at 440 nm was also observed upon its binding to
HSA [32]. Indeed, dihedral angles between pyrrole rings in PCB, calculated from the MD
study, confirmed that PCB bound to HSA adopts a more stretched conformation at both the
binding sites.
During the 300 ns of MD simulation, free HSA underwent three different conformations
(initial, transitional, and final). Upon PCB binding to site IB, HSA underwent only slight con-
formational change, indicating that the PCB binding site IB is mainly preformed and PCB
rigidifies it upon binding. In contrast, conformational adjustments of the HSA molecule by
PCB binding to site IIA was more permissible; at about 170 ns, conformational adjustment
was complete and the HSA structure was rigidified from that moment, although less than that
in the aforementioned case. The lower plot for Rg values of HSA-PCB(IB) during the entire
simulation period, and switch of Rg of HSA-PCB(IIA) to lower values after 170 ns implies that
the HSA-PCB complex has more compact conformation in comparison to free HSA. Analysis
of RMSF for individual subdomains demonstrated that PCB binding at site IB induces notice-
able increase in the rigidity of the subdomains IB and IIIB and increases flexibility in subdo-
main IIB, whereas PCB binding at site IIA induces prominent increase in the rigidity of
subdomain IIIB. Residues involved in PCB binding at site IB highly contributed to the rigidifi-
cation of subdomain IB, whereas residues involved in PCB binding at site IIA did not allow
increase in flexibility. Overall, PCB binding to site IB and IIA increased the rigidity of the
whole HSA structure for cca 5% and 2% respectively, supporting other results and demonstrat-
ing that PCB binding at any of the two sites stabilizes HSA structure.
CD and FT-IR measurements showed that binding of PCB caused a slight conformational
change of the protein, with an increase in its α-helical content. It has previously been reported
that binding of certain ligands such as vitamin B12 [15] and virstatin [33] may cause
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conformational change in HSA with an accompanying increase in its α-helical content and
protein structural stabilization. This phenomenon is quite striking for protein–ligand systems
with high affinities, e.g., binding of biotin to streptavidin causes the disappearance of the band
arising from unordered structure in FT-IR spectra [34].
CD and fluorescence melting curves of HSA in the presence and absence of PCB confirmed
that PCB binding leads to an increased protein thermal stability. Increase in HSA Tm was also
found upon binding of several other ligands to site IIA, such as warfarin [35], virstatin [33],
and hippuric acid [36]. Previous studies have found that increase in thermal stability induced
by ligand binding correlates with decrease in protein flexibility, i.e., increased protein packing
induces greater stability [37]. Therefore, binding of PCB to HSA increases rigidity, and conse-
quently, the thermal stability of HSA.
Trypsin digestion study showed that the HSA–PCB complex is more resistant to proteolysis
in comparison to free HSA. This is in accordance with previous findings that the binding of
some ligands to HSA, such as anionic azo-dyes [38] and bilirubin [39], a structural analog of
PCB, decreases the susceptibility of HSA to hydrolytic attack by trypsin. Increased compact-
ness and reduced flexibility of HSA induced by PCB binding protected the protein from pro-
teolytic degradation, as susceptibility to proteolysis is determined by exposure of peptide
bonds, as well as by mobility of protein segments containing these bonds. An important conse-
quence of the observed phenomenon may be that PCB, when bound to the major carrier pro-
tein, may prolong the protein’s half-life in plasma by making it less susceptible to proteases.
Our results also indicate that for proteins binding multiple ligands, conformational changes
upon binding of the tetrapyrrole ligand may have various effects on binding of other physio-
logically relevant ligands of HSA. There is no strict ligand specificity for the HSA-binding
sites, and HSA, as an indiscriminate ligand binder, binds a variety of ligands without extremely
high affinities. Each site in HSA is able to bind ligands of variable shapes and sizes owing to a
flexible protein structure and ability of three HSA domains for substantial relative movement.
Our study implies that PCB binding influences the binding of ligands to the other sites, mostly
by reducing their binding. This can be explained by the fact that bound PCB reduces HSA flex-
ibility, and thus limits HSA from adopting dynamic conformations necessary for other ligand
fittings.
HSA acts as a carrier for drugs, peptides, and small proteins (e.g., cytokines) allowing them
to circulate for as long a time as the half-life of HSA itself. Therefore, the actual concentration
of drugs, peptides, and small proteins in any compartment depends on their ability to bind
HSA and/or other plasmatic carrier proteins [14]. Our results directly imply that binding of
PCB to HSA will not only influence the protein’s ability to bind ligands, but may also effect
higher stability and longevity of the protein in plasma.
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CD spectral data were obtained after a total 2 min: 1 min of equilibration, and 1 min of spectra
recording. Temperature dependence of 1 μM HSA fluorescence emission spectra in the
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